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A B S T R A C T
Background: Cocaine use has been consistently associated with decreased gray matter volumes in the prefrontal
cortex. However, it is unclear if such neuroanatomical abnormalities depict either pre-existing vulnerability
markers or drug-induced consequences. Thus, this longitudinal MRI study investigated neuroplasticity and
cognitive changes in relation to altered cocaine intake.
Methods: Surface-based morphometry, cocaine hair concentration, and cognitive performance were measured in
29 cocaine users (CU) and 38 matched controls at baseline and follow-up. Based on changes in hair cocaine
concentration, CU were classiﬁed either as Decreasers (n=15) or Sustained Users (n=14). Surface-based
morphometry measures did not include regional tissue volumes.
Results: At baseline, CU displayed reduced cortical thickness (CT) in lateral frontal regions, and smaller cortical
surface area (CSA) in the anterior cingulate cortex, compared to controls. In Decreasers, CT of the lateral frontal
cortex increased whereas CT within the same regions tended to further decrease in Sustained Users. In contrast,
no changes were found for CSA and subcortical structures. Changes in CT were linked to cognitive performance
changes and amount of cocaine consumed over the study period.
Conclusions: These results suggest that frontal abnormalities in CU are partially drug-induced and can recover
with decreased substance use. Moreover, recovery of frontal CT is accompanied by improved cognitive per-
formance conﬁrming that cognitive decline associated with cocaine use is potentially reversible.
1. Introduction
Results from recent wastewater analyses from 2017 have revealed a
worrying picture about cocaine consumption in Europe as they em-
phasize a strong upward trend for detected benzoylecgonine (main
metabolite of cocaine) levels across many European cities (EMCDDA,
2018). These numbers are alarming, as cocaine consumption is
associated with several long-term health conditions along with dis-
rupted social relationships, thus, leading to a high burden for society
and economy (Degenhardt and Hall, 2012; Nutt et al., 2007). Beyond
that, cocaine use is linked to considerable cognitive deﬁcits (Spronk
et al., 2013; Vonmoos et al., 2013) and alterations in brain structures
(Ersche et al., 2013b; Mackey and Paulus, 2013). Diminished gray
matter (GM) volumes have been recurrently reported especially in
https://doi.org/10.1016/j.nicl.2019.101652
Received 5 July 2018; Received in revised form 4 December 2018; Accepted 2 January 2019
⁎ Corresponding authors at: Experimental and Clinical Pharmacopsychology, Department of Psychiatry, Psychotherapy, and Psychosomatics, Psychiatric Hospital,
University of Zurich, Lenggstrasse 31, CH-8032 Zurich, Switzerland.
E-mail addresses: sarah.hirsiger@gmail.com (S. Hirsiger), quednow@bli.uzh.ch (B.B. Quednow).
NeuroImage: Clinical xxx (xxxx) xxxx
2213-1582/ © 2019 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY license 
(http://creativecommons.org/licenses/BY/4.0/).
Please cite this article as: Hirsiger, S., NeuroImage: Clinical, https://doi.org/10.1016/j.nicl.2019.101652
frontal brain areas, insula, and the thalamus (e.g., Ersche et al., 2011;
Kaag et al., 2014; Lim et al., 2008; Sim et al., 2007). Speciﬁcally, GM
alterations in frontal regions have been associated with cognitive
functioning (Hanlon et al., 2011), decision-making performance
(Tanabe et al., 2009), and trait impulsivity of chronic cocaine users
(CU) (Crunelle et al., 2014; Moreno-Lopez et al., 2012).
Although there is consensus about reduced cortical GM volumes in
chronic CU, results for subcortical volumes, especially for the striatum,
are inconsistent and conﬂicting. Comparing data between dependent
CU and healthy controls, spatially distinct increases in striatal GM vo-
lume (Ersche et al., 2011), smaller GM volumes in the striatum (Barros-
Loscertales et al., 2011), and also the absence of any diﬀerences have
been reported (Garza-Villarreal et al., 2016). Cross-sectional neuroa-
natomical alterations seen in CU are commonly interpreted as a con-
sequence of cocaine use as studies found associations between the
duration of cocaine intake and GM abnormalities (Barros-Loscertales
et al., 2011; Ersche et al., 2011; Ide et al., 2014). This claim is partly
supported by a recent longitudinal study demonstrating that reduced or
ceased cocaine intake over a study period of six month was associated
with an increase in GM volume in the inferior frontal gyrus (IFG) and
ventromedial prefrontal regions (Parvaz et al., 2017). Additionally,
increased GM volume of the IFG was positively associated with cogni-
tive ﬂexibility performance, which was examined only in CU. Further-
more, cocaine use intensity of the participants was only assessed by self-
reports. Recovery of cognitive performance after ceasing cocaine intake
was previously shown by our laboratory especially for attention and
memory performance (Vonmoos et al., 2014). The same longitudinal
study also found evidence that increased cocaine intake was sig-
niﬁcantly associated with reduced cognitive performance especially for
working memory (Vonmoos et al., 2014).
However, there is a second possible interpretation of the reported
cross-sectional GM alterations. Next to substance-induced plasticity,
these diﬀerences in brain structures might depict pre-existing vulner-
ability markers, a possibility discussed in a recent sibling study. While
both siblings, one addicted to cocaine whereas the other had no history
of drug intake, showed increased GM volume in subcortical regions
compared to non-related controls, a decrease in GM volume in the
prefrontal cortex was only applicable in the cocaine dependent sibling
(Ersche et al., 2012). As brain structures are suggested to be highly
heritable (Wright et al., 2002), the authors concluded that the sub-
cortical enlargements are potential endophenotypes for cocaine addic-
tion.
Taken together, it is not fully understood whether cortical altera-
tions found in CU are predisposed or cocaine-induced (or both).
Moreover, it is unclear how prolonged use of cocaine, in contrast to a
reduction in cocaine intake aﬀects GM. Finally, the neuronal basis of
well-documented cognitive deﬁcits in CU is not yet clear (Vonmoos
et al., 2014). In this current longitudinal study we therefore collected
data from stimulant-naïve controls and CU with reduced/ceased but
also with sustained/increased cocaine use at baseline and after a time
interval of at least six and up to 53months. The group categorization
was built on objective toxicological hair analyses covering the use of
the last 6 months. Surface-based morphometry measures of six regions
of interest in the frontal lobe and volumetric measures of subcortical
structures were analyzed. In contrast to voxel-based morphometry,
surface-based morphometry oﬀers the possibility to analyze cortical
thickness (CT) and cortical surface area (CSA) separately. Disentangling
these two parameters is important, as CT and CSA have been described
as having minimal genetic relationship and stand for diﬀerent facets of
GM (Rakic, 1988, 1995, 2007). Thus, we anticipated ﬁnding new in-
formation about possible neuroplasticity not only in participants de-
creasing but also in participants with sustained cocaine consumption.
With additional data on key cognitive functions (sustained attention
and working memory), we aimed to gain more insight into the possible
neuroanatomical underpinnings of cognitive deﬁcits in CU.
We hypothesized CT/CSA in the six frontal regions of interest and
cognitive performance to be lower in CU than in controls at baseline.
Moreover, severity of drug use was expected to correlate negatively
with cortical variables. In contrast, positive associations were antici-
pated between cognitive performance and cortical parameters. We
further hypothesized dose-dependent negative alterations in frontal
regions and in accordance with Parvaz et al. (2017) we expected that
CT and CSA are negatively aﬀected by cocaine consumption and that
those changes were more pronounced with higher amount of cocaine
intake during the study interval. Moreover, cortical changes were also
expected to be positively associated with cognitive change scores.
Subcortical structures were analyzed in an explorative fashion as no
clear picture could be drawn from the previous literature.
2. Material and methods
2.1. Participants
A total of 38 healthy controls and 29 CU were included in this study
(for recruitment and selection details see Suppl. Methods 1). To be
eligible to participate CU had to report cocaine as primary drug of use
with a consumption level of> 0.5 g per month, and an abstinence
duration of< 6months to ensure regular and recent use to ensure that
all the participants were current users at baseline. Exclusion criteria for
CU were the presence of DSM-IV Axis I adult psychiatric dis-
orders—except for cocaine, cannabis, nicotine, alcohol abuse/depen-
dence, attention deﬁcit hyperactivity disorder (ADHD), and a previous
depressive episode. Controls were excluded if they displayed a current
or previous DSM-IV Axis I psychiatric disorders (except for nicotine
dependence), and illegal drug use of> 15 lifetime occasions or during
the past 6months with the exception of cannabis. Before the testing
session, participants were asked to abstain from illegal substances for at
least 72 h and not to consume alcohol for 24 h. Urine samples were
collected to verify self-reports. When available, 6 cm hair samples were
cut from the occiput enabling to objectively estimate drug use during
the last six months. Hair samples were analyzed with liquid chroma-
tography-tandem mass spectrometry (see Suppl. Methods 2). Data from
these 6-months hair samples were used for a) conﬁrmation of regular
cocaine use (participants were only included if cocaine hair con-
centration was at least 0.5 ng/mg, an excepted threshold for reliable
cocaine detection; Bush, 2008; Cooper et al., 2012); b) conﬁrmation
that cocaine is the primary used illicit drug, and c) for separation of the
CU into two groups (see Suppl. Methods 2 for urine and hair toxicology
analyses). Participants were mostly right handed (94.0%) and there was
no group diﬀerence in handedness (x22= 2.49, P= .29). The ethics
committee of the Canton of Zurich approved the study, which was in
accordance with guidelines from the Helsinki declaration. All partici-
pants gave written informed consent and were compensated for their
participation.
2.2. Group assignment
The included 29 CU were classiﬁed into two groups using hair
concentration for cocaine and related metabolites: Decreasers or
Sustained Users (Suppl. Fig. 1). Participants were categorized as De-
creasers based on a combination of an absolute and relative change in
their hair cocaine parameters from baseline to follow-up: There had to
be an absolute decrease in cocaine of at least 0.5 ng/mg from baseline
to follow-up and the more robust parameter cocainetotal (=co-
caine+ benzoylecgonine+ norcocaine; Hoelzle et al., 2008) had to be
at least 10% less at follow-up than at baseline (criteria based on
Vonmoos et al., 2014). The Sustained Users included participants, which
did either not change their consumption behavior or increased their
cocaine intake based on cocainetotal levels. In addition, the Sustained
Users also included one participant meeting the criterion for the De-
creasers but had a measured cocainetotal concentration at the follow-up
time point which was above a value of 27.8 ng/mg. This threshold was
S. Hirsiger et al. NeuroImage: Clinical xxx (xxxx) xxxx
2
chosen in accordance to a study, which showed that dependent CU had
on average hair cocainetotal concentrations of 27.8 ng/mg (Vonmoos
et al., 2013). With a sustained dependent consumption behavior we did
not expect an improvement either in structural brain measures or
cognitive performance. For three CU (1 Decreaser, 2 Sustained Users)
hair samples were not available at baseline. Those participants were
either categorized with the help of the amount of cocainetotal con-
centration measured at follow-up (two had larger concentration of co-
cainetotal than 27.8 ng/mg, thus were categorized as Sustained Users)
and/or the reported cocaine use at baseline versus follow-up (one
participant with cocainetotal of 2.15 ng/mg at follow-up reported de-
creased cocaine consumption at the second time point, thus was cate-
gorized as Decreaser). For one participant, no hair sample could be
collected at any time point. Due to his reported consistent high cocaine
consumption of> 30 g per week, the participant was classiﬁed as Sus-
tained User. Based on these stipulations 15 CU were categorized as
Decreasers and 14 were classiﬁed as Sustained Users.
2.3. Procedure
After the baseline measurement a subsequent follow-up data
collection was conducted after a minimum of 6months (interval dura-
tion: M=19months, max. duration 53months). At both time points,
MRI scans as well as demographical information and drug use para-
meters were collected at the same day. A trained psychologist con-
ducted a clinical interview to determine the presence of DSM-IV Axis I
diagnoses (MINI/SCID-I; APA, 1994). Beyond hair testing, all subjective
data on drug use was assessed by the Interview for Psychotropic Drug
Consumption (Quednow et al., 2004). In addition, the brief version of
the Cocaine Craving Questionnaire (CCQ) was used to identify current
cocaine craving (Sussner et al., 2006). Participants were additionally
asked to complete the Beck Depression Inventory (BDI; Beck et al.,
1961) to reveal current severity of depression. Smoking habits were
assessed by the use of the Fagerström Test of Nicotine Dependence
(Heatherton et al., 1991). Lastly, a standard German vocabulary test to
estimate verbal intelligence (IQ; Lehrl, 1999) and the ADHD self-rating
scale (ADHD-SR; Roesler et al., 2004) to estimate ADHS symptoma-
tology, were applied. As we did not expect changes in ADHD ratings
and verbal intellectual performance over the study period, both ques-
tionnaires were only carried out at baseline.
Cognitive data for sustained attention (n=51) and working
memory (n=63) performance was available for a large subset of the
Fig. 1. Cortical group diﬀerences at baseline.
Group diﬀerences for cortical measures for the six regions of interest. (A) Mean cortical thickness (in mm) and standard errors. All values corrected for age, verbal IQ,
and ADHD-SR score. (B) Mean cortical surface area (×103 in mm2) and standard errors. All values corrected for age, verbal IQ, ADHD-SR score, and total surface
area.
*P < .05 corrected for multiple comparisons. Cohen's d controls vs. cocaine users.
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included participants. Attention and working memory performance
were investigated because those “top-down” cognitive abilities are
strongly linked to frontal cortex functioning (D'Esposito and Postle,
1999; Pardo et al., 1991). Moreover, previous longitudinal data from
our laboratory revealed that increased cocaine use was particularly
associated with increased deﬁcits in working memory performance
(Vonmoos et al., 2014). Recreational CU displayed the strongest im-
pairments in cognitive tasks measuring sustained attention and in turn
fully recovered from attention deﬁcits when quitting their cocaine in-
take completely at follow-up (Vonmoos et al., 2013, 2014). Sustained
attention performance was assessed by the discrimination performance
A` measured with the Rapid Visual Processing (RVP) test from the
Cambridge Neuropsychological Test Automated Battery (CANTAB,
http://www.cantab.com). For the RVP task, 28 controls, 12 Decreasers,
and 11 Sustained Users had available data at both measurement points.
Verbal working memory was measured by the sum score of the Letter
Number Sequencing Task (LNST, Wechsler, 1997) and was completed
by a subset of 63 participants (37 controls, 14 Decreasers, and 12 Sus-
tained Users). At baseline cognitive tests were conducted on average
17 weeks (RVP) and 14weeks (LNST) prior to MRI acquisition. There
were no group diﬀerences in time between cognitive testing and MRI
acquisition for both cognitive tasks (RVP: F2,48= 1.21, P= .31,
pη2= 0.05; LNST: F2,60= 1.68, P= .20, pη2= 0.05). At follow-up,
cognitive and MRI data were collected at the same day (additional in-
formation about the procedure can be found in Suppl. Methods 3).
2.4. Image data acquisition
At both time points, MRI data for all subjects were collected on the
same 3 T Philips Achieva whole-body scanner equipped with a 32-
channel receive head coil, using the same standard T1-weighted 3D
magnetization-prepared rapid gradient echo (MPRAGE) pulse sequence.
Image parameter were: repetition time (TR)=8.08ms, echo time
(TE)= 3.7ms, ﬁeld of view (FOV)= 240×240 mm2, 160 slices, voxel
size of 1×1×1mm3.
2.5. Surface-based MRI data processing
To evaluate changes in CT and CSA FreeSurfer (v5.3.0) was used.
FreeSurfer is a freely available (http://surfer.nmr.mgh.harvard.edu/),
automated, image analysis suit that has been well documented in
former publications (Dale et al., 1999; Fischl and Dale, 2000; Fischl
et al., 1999, 2004). For more details on MRI data processing please see
Suppl. Methods 4. After cross-sectional preprocessing, FreeSurfer's al-
ready established longitudinal pipeline (Reuter et al., 2010, 2012),
previously shown to be highly reliable (Liem et al., 2014), was applied.
To extract CT and CSA for several regions of interests (ROI), the cortex
was parcellated by the use of the Desikan-Killiany Atlas (Desikan et al.,
2006). As most pronounced alterations between CU and healthy con-
trols were reported within the frontal lobe, we restricted our analysis to
ROI within this area (Ersche et al., 2013b). Thus, our analysis included
the superior frontal gyrus (SFG), middle frontal gyrus (MFG; caudal and
rostral middle frontal gyrus), IFG (pars opercularis, orbitalis, and tri-
angularis), medial orbitofrontal cortex (OFC), lateral OFC, and anterior
cingulate cortex (ACC; caudal and rostral anterior cingulate cortex).
Either the mean (for CT) or the sum (for CSA) of the mentioned subparts
for each ROI was calculated. As ROI in both hemispheres were sig-
niﬁcantly correlated (see Suppl. Methods 5) we averaged the CT and
CSA for each ROI from both hemispheres to reduce the number of
comparisons. Moreover, as we aimed to analyze CT and CSA separately
we refrained to weight the ROIs for the CSA when analyzing CT, as we
were afraid to blur information from CSA into our CT analyses (for
more information see Suppl. Methods 4). See Suppl. Fig. 2 for the six
cortical ROI used in this study.
2.6. Subcortical volumetric MRI data processing
To analyze subcortical structures the MAGeTbrain-Toolbox
(Chakravarty et al., 2013) was used. This automatic segmentation al-
gorithm was employed because it has recently been shown to be nearly
as accurate as segmentations done by elaborate and costly manual
tracing (the “gold standard” of segmentation; Chakravarty et al., 2013;
Makowski et al., 2018). In addition, it has been reported to be more
precise than other tools such as FreeSurfer and FSL FIRST (Makowski
et al., 2018). All T1-weighted images were ﬁrst preprocessed (non-
uniformity correction (iterative n4), brainextraction, cropping) using
the minc-bpipe-library (https://github.com/CobraLab/minc-bpipe-
library). The preprocessed images were then further segmented using
the MAGeTbrain-Toolbox (Chakravarty et al., 2013) to extract volume
measures for the thalamus, globus pallidus, and striatum (https://
github.com/CobraLab/MAGeTbrain). For more information regarding
data processing please see Suppl. Methods 4. As for the surface-based
neuroanatomical parameters, volumes for subcortical structures were
averaged for the left and right hemisphere (correlations are reported in
the Suppl. Methods 5).
2.7. Statistical analyses
Group diﬀerences in demographic and substance use variables were
analyzed using independent t-tests or ANOVAs, as applicable.
Frequency data were evaluated by means of Pearson's chi-square tests.
Group diﬀerences in neuroanatomical parameters (CT, CSA, and sub-
cortical volume) and in cognitive performance scores at baseline were
conducted by analyses of covariance (ANCOVA). Using Pearson's pro-
duct-moment correlation analyses, associations between neuroanato-
mical measurements that showed a signiﬁcant group eﬀect at baseline
and cocaine consumption parameters were conducted in the CU group.
As we had the a priori-hypothesis that cortical structures are negatively
associated with duration of cocaine use, cumulative dose of cocaine,
grams consumed per week and positively with age of onset, one-tailed
correlations were conducted. Correlations including the duration and
the cumulative dose of cocaine consumption were adjusted for age
because of the strong link between those variables and age. To in-
vestigate if there is a link between alterations in cortical neuroanato-
mical parameters and cognitive ability, we additionally analyzed the
relation between measures for CT/CSA and cognitive outcome scores at
baseline (one-tailed).
For longitudinal evaluation mixed design ANCOVAs including
controls, Decreasers, and Sustained Users, were used. Sidak-corrected
pairwise pre-post comparisons and follow-up group comparisons were
Fig. 2. Subcortical measures at baseline.
Subcortical mean volume measures (×103 in mm3) and standard errors in co-
caine users and controls. All values corrected for age, verbal IQ, ADHD-SR
score, and ICV.
None of the group diﬀerences survived multiple comparisons correction.
Cohen's d controls vs. cocaine users.
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conducted after a signiﬁcant omnibus test (group ∗ time). To correct for
cognitive test-retest eﬀects, the CU change scores were adjusted by
subtracting the controls mean change scores, as controls performance
over the study period was assumed to be constant. To relate neuroa-
natomical changes found to cocaine use during the test interval, cor-
relations were conducted between the measured change in neuroana-
tomical structures and the cumulative amount of cocaine consumed
between the two measurement points in the CU groups. Similar to the
baseline analyses, we additionally linked cognitive change scores with
possible changes found in CT/CSA and subcortical volumes.
All ANCOVAs (cross-sectional and longitudinal) were adjusted for
ADHD-SR score and IQ scores, two variables that have formerly been
linked to neuroanatomical alterations, cognitive performance and
substance consumption in general (Preller et al., 2014; Proal et al.,
2011; Schnack et al., 2015; Vonmoos et al., 2013). Group comparisons
at baseline were additionally corrected for age, a recommended cov-
ariate in MRI research (Barnes et al., 2010). Compared to baseline,
Sustained Users consumed signiﬁcantly more grams of alcohol per week
than the Decreasers at follow-up (F1,27= 6.64, P= .016, d= 0.87).
Thus, longitudinal ANCOVAs were additionally adjusted for the amount
of alcohol consumed between baseline and follow-up, and the time
between the two measurements. All analyses including either CSA or
subcortical volumes, total surface area or ICV were additionally in-
cluded as a covariate, respectively. Moreover, except for duration of
cocaine use and age of onset, the consumption variables were not
normally distributed and were therefore ln-transformed for correlation
analyses. The level of signiﬁcance for all tests was set to P < .05.
Additionally, a false discovery rate (FDR) correction was used for cross-
sectional group comparisons for each modality and time point sepa-
rately (signiﬁcant ﬁndings are indicated with an asterisk, Benjamini
and Hochberg, 1995). All statistical analyses were performed using IBM
SPSS Statistics 22.0 (SPSS Inc.) for Mac.
3. Results
3.1. Demographic characteristics
Controls and both CU groups were matched for age, gender, and
time between the two measurements (Table 1). Similar to former stu-
dies including CU and controls, Decreasers and Sustained Users diﬀered
from the control group in the subjective rating of ADHD symptoms, and
BDI score (Vonmoos et al., 2013, 2014). Sustained Users had a sig-
niﬁcantly lower verbal IQ than the controls and Decreasers. At baseline
both user groups showed similar cocaine consumption severity in-
dicated by the lack of group diﬀerences in subjective as well as objec-
tive (hair concentrations) measures. In contrast, a ten-fold higher co-
caine concentration in hair samples was found in Sustained Users
compared to Decreasers at follow-up. Furthermore, the cocainetotal
concentration and subjectively reported amount of cocaine used per
week were strongly correlated at both time points (baseline: r
(23)= 0.58, P= .0026; follow-up: r(22)= 0.63, P= .0012). Finally, at
baseline Decreasers (80%) and Sustained Users (71%) did not diﬀer re-
garding their frequency of a DSM-IV diagnosis of current cocaine de-
pendence (χ2= 0.29, P= .590). However, more Sustained Users (79%)
than Decreasers (33%) were currently dependent at the follow-up
(χ2= 5.99, P= .014). At the follow-up four Decreasers actually stopped
cocaine intake for at least 6 months as conﬁrmed by hair analyses.
3.2. Baseline group diﬀerences in neuroanatomical parameters and
cognition
At baseline, signiﬁcant group eﬀects were found for CT in the SFG,
and IFG as well as in the lateral OFC (F1,62= 5.59–6.83, P= .021–0.11;
Fig. 1A and Suppl. Table 1). In all of the analyzed ROI, thinner cortices
were found in CU compared to controls. Group diﬀerences were ad-
ditionally found in the ACC where CU showed a signiﬁcantly smaller
CSA than controls (Fig. 1B and Suppl. Table 1). For subcortical struc-
tures, we found no signiﬁcant diﬀerences after adjustment for multiple
comparisons (Fig. 2, Suppl. Table 1). All results remained the same
when gender was included as an additional covariate (Suppl. Table 2).
Moreover, ADHD-SR score did not signiﬁcantly explain any variance in
the baseline analyses for CT and CSA. However, the ADHD-SR score did
signiﬁcantly explain variance in the model investigating the globus
pallidus volume diﬀerence between the groups (P= .003) but not for
other subcortical structures. Moreover, the two CU groups did not diﬀer
in any measured GM variables (CT, CSA, subcortical volumes) at
baseline (Suppl. Table 3).
In line with the literature, CU scored signiﬁcantly lower in tests
measuring sustained attention (controls mean= 0.92 SE= 0.01, CU
mean=0.89 SE=0.01; F1,47= 7.12, P= .010, d= 0.80) and working
memory (controls mean=16.6 SE=0.6, CU mean=13.8 SE=0.7;
F1,59= 8.44, P= .005, d=0.82) compared to controls.
3.3. Baseline associations between neuroanatomical parameters, cocaine
use, and cognition
To evaluate the association between cocaine use parameters and
cortical measurements, we only analyzed ROI and subcortical structures
where signiﬁcant group diﬀerences were found. Additionally, as all
signiﬁcant regions of CT (i.e., SFG, IFG, and lateral OFC) showed the
same pattern of reduction, those ROI were further averaged to one re-
gion in order to avoid the problem of alpha-error accumulation.
Signiﬁcant associations were found between the average CT of the three
signiﬁcant ROI and the cumulative lifetime consumption (in g) (r
(26)=−0.33, P= .044) and the duration of cocaine use (r
(26)=−0.35, P= .036; Suppl. Table 4). Speciﬁcally, the larger the
amount of cocaine used and the longer cocaine had been used, the
thinner the lateral frontal regions were (Suppl. Fig. 3A and B). No as-
sociations were found for the CSA (ACC). Additionally, correlations
with other substances did not reach signiﬁcance and are reported in
Suppl. Table 5. Importantly, the amount of cigarettes smoked a day was
not signiﬁcantly correlated with alterations seen in CT, and CSA (Suppl.
Table 5) supporting earlier ﬁndings that show that frontal GM altera-
tions found in CU are not associated with smoking severity (Crunelle
et al., 2014).
There was a signiﬁcant association between CT and sustained at-
tention (r(21)= 0.36, P= .048) but the correlation with working
memory was not signiﬁcant (r(24)=−0.22, P= .15). Moreover, cor-
relation analyses between CSA (ACC) and both cognitive measures were
not signiﬁcant (RVP: r(21)= 0.26, P= .12; LNST: r(24)= 0.14,
P= .25).
3.4. Longitudinal changes in neuroanatomical parameters and cognition
Applying mixed ANCOVAs signiﬁcant group ∗ time interactions
were found for CT in the SFG (F2,60= 4.16, P= .020, pη2= 0.12), MFG
(F2,60= 4.64, P= .013, pη2= 0.13), and the IFG (F2,60= 3.23,
P= .047, pη2= 0.10; Fig. 3). For CT within the medial, lateral OFC,
and ACC no signiﬁcant interactions were found (F2,60= 1.23–2.88,
P= .06–0.30, pη2= 0.04–0.09). A lack of signiﬁcant interaction eﬀects
was also apparent in all ROI for CSA (F2,59= 0.31–3.06, P= .05–0.96,
pη2= 0.001–0.09) and subcortical structures (F2,59= 0.02–1.86,
P= .16–0.98, pη2= 0.001–0.06). The results remained the same when
the cumulative amounts of cannabis consumption or tobacco smoking
(cigarettes per day at follow-up) were added as additional covariates in
separate ANCOVAs. Subsequent Sidak-corrected tests for group com-
parisons at follow-up revealed that CT was signiﬁcantly thicker in
controls compared to Sustained Users in the SFG (P= .026), MFG
(P= .008), and IFG (P= .047). There were no group diﬀerences found
between the controls and Decreasers at follow-up (P= .43–0.56). Pair-
wise Sidak pre-post comparisons additionally showed that Decreasers
signiﬁcantly increased their CT within all three regions where
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signiﬁcant omnibus tests (group*time) were found (SFG: P= .018;
MFG: P= .009; IFG: P= .022). Within the same regions, CT in Sus-
tained Users seemed to further decrease over time, but this pre-post
comparison did not reach signiﬁcance (P= .15–0.39).
The results for the two cognitive measures revealed a signiﬁcant
group ∗ time interaction for sustained attention (F2,44= 9.07,
P= .0005, pη2= 0.29; Fig. 4), but not for working memory
(F2,56= 1.32, P= .27, pη2= 0.05). Subsequent post-hoc analyses for
RVP showed that there were no signiﬁcant group comparisons applic-
able at follow-up (controls vs. Decreasers: P= 1.0; controls vs. Sustained
Users: P= .81). However, pairwise Sidak pre-post comparisons showed
that the Decreasers had a performance improvement when comparing
performance scores at baseline vs. follow-up (P= .00003).
3.5. Associations between changes in neuroanatomical parameters, cocaine
consumption, and cognition
Again, only regions where a signiﬁcant time ∗ group omnibus test
was found were further analyzed. These three ROI were again averaged
to one region in order to reduce the risk of multiple comparisons.
Thickness change in this merged region was signiﬁcantly associated
with the cumulative amount of cocaine used within the time interval (r
(26)=−0.32, P= .047; Suppl. Fig. 4). The CT change of this region
was not associated with other illicit substances/alcohol used during the
study period (Suppl. Table 6). Moreover, CT changes was also not as-
sociated with ADHD-SR scores neither in the entire sample (r
(65)=−0.11, P= .19, 1-tailed) nor when we restricted our calcula-
tions to the CU groups (r(27)=−0.03, P= .44, 1-tailed). Regrettably,
for smoking we do not have reliable data for cumulative use of cigar-
ettes over the study interval. However, the amount of cigarettes smoked
per day at follow-up did not correlate signiﬁcantly with changes seen in
CT (r(27)= 0.05, P= .40, 1-tailed).
Furthermore, the change in CT was positively linked to attention
performance within the CU group (r(21)= 0.36, P= .044; Suppl.
Fig. 5), but not to working memory (r(24)= 0.26, P= .10). Moreover,
the relationship between CT change and attention performance re-
mained signiﬁcant when controlling for cocaine consumption within
the interval (r(19)= 0.40, P= .035). In contrast, the aforementioned
association between CT change and cumulative cocaine consumption
did not remain signiﬁcant when controlling for attention performance
change (r(19)=−0.27, P= .12). However, the downshift of the latter
correlation was not signiﬁcant (from r=−0.32 to −0.27; z= 0.16,
P= .44), so that we would not like to overinterpret this result.
4. Discussion
The main goal of this study was to investigate whether consistently
reported GM alterations in CU might be substance-induced and poten-
tially reversible. With a longitudinal study design including individuals
decreasing or increasing their cocaine consumption, we anticipated
getting valuable information about the possible plasticity of neuroa-
natomical structures. Moreover, we were interested to link our ﬁndings
to changes in cognitive performance to further enhance our knowledge
about potential neuroanatomical underpinnings of well-documented
working memory and attention deﬁcits in CU (Jovanovski et al., 2005;
Fig. 3. Changes in cortical thickness.
Change in cortical thickness (in mm) from baseline to follow-up. Superior
frontal gyrus: Decreasers P= .018 Sustained Users P= .16; Middle frontal gyrus:
Decreasers P= .009 Sustained Users P= .15; Inferior frontal gyrus: Decreasers
P= .022 Sustained Users P= .39;
Sidak post-hoc tests: *P < .05. All analyses were corrected for verbal IQ,
ADHD-SR score, the amount of alcohol consumed between baseline and follow-
up, and the time interval between the two measurements.
Fig. 4. Changes in attention performance.
Change in sustained attention performance from baseline to follow-up. The
analysis was corrected for verbal IQ, ADHD-SR score, the amount of alcohol
consumed between baseline and follow-up, and the time interval between the
two measurements. The follow-up values were additionally adjusted for test-
retest eﬀects. Decreasers P= .00003 Sustained Users P= .11;
Sidak post-hoc tests: *P < .05.
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Vonmoos et al., 2013). Using a surface-based morphometry approach
we investigated CT and CSA (instead of volumetric measures) of the
cortex of CU and controls. Our main results showed CT recovery in
lateral frontal regions after decreasing or ceasing cocaine intake. In
contrast–albeit not signiﬁcantly–CT further declined in Sustained Users
in the same regions over the study period. These CT changes were ad-
ditionally associated with the cumulative amount of cocaine consumed
within the time interval and changes in attention performance scores.
To our knowledge, this study is the ﬁrst to show both, possible recovery
but also further loss of CT within the frontal lobe in chronic CU.
Moreover, CT changes might be the cause of cognitive diﬃculties seen
in CU. Thus, our ﬁndings provide new target regions for possible
therapeutic interventions.
4.1. Baseline associations between neuroanatomical parameters, cocaine
use, and cognition
In a ﬁrst step, we replicated former ﬁndings of apparent diminished
frontal GM volume in CU (for a review see: Ersche et al., 2013b; Hanlon
et al., 2011; Ide et al., 2014). We found lower CT in the SFG, IFG, and
lateral OFC in CU compared to controls. CT within ACC, and the medial
OFC was not signiﬁcantly diﬀerent between the two groups. This was
unexpected, as alterations within medial frontal regions have been most
consistently reported (Ersche et al., 2011; Franklin et al., 2002;
Matochik et al., 2003). Interestingly, we found signiﬁcant smaller ACC
surface areas in CU compared to controls, while no signiﬁcant CSA
diﬀerences were found in all other ROI (d= 0.02–0.29). Although both
cortical measures (CT and CSA) are reported to be heritable, they seem
to be genetically unrelated (Panizzon et al., 2009; Winkler et al., 2010).
Moreover, the two structural properties are also suggested to represent
diﬀerent facets of the cortex according to the radial unit hypothesis
(Rakic, 1988, 1995): Whereas the size of CSA is believed to be related to
the number of cortical columns, CT is related to the number, size, and
packing density of cells within such a column (Rakic, 1988). Our results
indicate that medial and lateral frontal lobe GM abnormalities might be
the result of diﬀerent underlying mechanisms. Thus, GM alterations
within lateral areas might be due to either the reduction of cell volume,
cell death, and loss of dendritic branching or a combination of these
possibilities. In contrast, the CSA diﬀerences seen within the ACC could
be more related to a lower amount of cortical columns in this area. In
general, our ﬁndings highlight the importance of analyzing these two
independent variables of cortical volume separately.
With respect to subcortical structures, we found no diﬀerences be-
tween CU and healthy controls after correction for multiple compar-
isons. However, we would like to point out that the group diﬀerence
regarding thalamus volume reached at least a medium eﬀect size
(d= 0.46). Compared to consistently shown cortical abnormalities,
results regarding subcortical structures in CU are partially inconsistent:
while smaller thalamus volumes within CU have been conﬁrmed by a
meta-analysis (Ersche et al., 2013b), results for striatum abnormalities
are rather contradicting. Larger (Ersche et al., 2011, 2012) as well as
smaller striatum volumes (Barros-Loscertales et al., 2011; Schuch-Goi
et al., 2017) in addition to lack of such a diﬀerence have been reported
(Ersche et al., 2013b; Garza-Villarreal et al., 2016). These discrepancies
could be related to methodological reasons such as sample character-
istics, but also to variations in sample size, as the eﬀects on thalamic
and striatal structures might be subtler and more participants are
needed to indicate subcortical alterations compared to cortical GM
diﬀerences (Mackey and Paulus, 2013) (see also below). In addition,
discrepancies could also emerge from diﬀerent covariates used (e.g.,
age, ADHD symptoms). Moreover, in this study, an automatic seg-
mentation algorithm was employed. Manual segmentation, when per-
formed by a well-trained individual, has been shown to be more reliable
than automated segmentation. However, manual segmentation is
highly time consuming – speciﬁcally in large MRI data sets, such as
ours, therefore simply not feasible – and can introduce biases and errors
(Boccardi et al., 2011). In contrast, automated segmentation techniques
have been shown to achieve reliable and reproducible segmentations of
brain areas and have demonstrated the ability to capture brain changes
associated with disease (Chakravarty et al., 2013; Fischl et al., 2002;
Makowski et al., 2018).
As hypothesized, we also found reduced cognitive performance le-
vels in CU compared to controls within both cognitive domains tested.
This stands in agreement with earlier studies reporting pronounced
deﬁcits in dependent but also recreational users' attention and working
memory performance (Jovanovski et al., 2005; Vonmoos et al., 2013).
Moreover, we found a relationship between the CU's sustained attention
deﬁcits and lower frontal CT. Worse attention performance seen in CU
might therefore be due to thinning within the lateral frontal lobe in CU.
Additionally, we investigated the association between CT and con-
sumption variables and found the higher the cumulative consumed
cocaine amount was, and the longer cocaine has been used, the thinner
the lateral frontal cortex regions were. Duration of cocaine intake was
formerly linked to diminished GM volume within similar regions as in
our study (e.g., SFG, MFG, IFG; Barros-Loscertales et al., 2011; Lim
et al., 2008).
4.2. Longitudinal changes in neuroanatomical parameters and cognition
4.2.1. Regional speciﬁcity in cortical thickness changes
The longitudinal analyses conducted in the second step of this study
strengthen the notion of possible cocaine-induced alterations within the
frontal cortex. Our ﬁndings indicate that decreasing cocaine con-
sumption was associated with increasing CT at follow-up. Such a GM
recovery was also previously described in another longitudinal study
(Parvaz et al., 2017). Investigating GM changes in abstinent CU the
authors found recovery in GM volumes in the IFG and ventromedial
prefrontal regions (Parvaz et al., 2017). The lack of ventromedial pre-
frontal recovery in our study might be due to the fact that 11 of the 15
Decreasers were still using cocaine. Thus, our data suggest that ven-
tromedial prefrontal regions might be more sensitive to cocaine ex-
posure and only recover when intake is completely ceased. In addition,
also former cross-sectional data from diﬀerent abstainer groups de-
picted a positive association between days of abstinence and GM vo-
lume (Hanlon et al., 2011). However, to the best of our knowledge, this
is the ﬁrst study that longitudinally investigates changes in groups of
CU with decreased and sustained cocaine intake using hair testing as an
objective determination of cocaine use. In contrast to participants who
decreased their consumption, subjects with increased or sustained high
use of cocaine showed a tendency of further decreased frontal CT. The
lack of signiﬁcance for this CT change in Sustained Users is not sur-
prising as they already reported a relatively long duration of cocaine
use with a mean of eight years at baseline. They had a cumulative
lifetime intake of about 2 kg cocaine, thus, the additional 290 g that
they had consumed in average over the study interval was possibly too
small to cause another signiﬁcant decline.
4.2.2. Possible mechanisms for longitudinal cortical thickness changes
Next to a signiﬁcant CT recovery in Decreasers, CT seemed to further
decline with ongoing use of cocaine. This additional CT decline with
sustained cocaine use would support the notion of an ongoing neuro-
plastic or neurotoxic eﬀect. This suggestion is further supported by a
study that found sustained smaller frontal GM volume in CU who were
abstinent for 5 years (Tanabe et al., 2009). Similarly, Decreasers had still
lower CT than controls at follow-up. However, due to the lack of ex-
isting longitudinal data, it is not known how long a possible full GM
recovery would take; thus, the interval in our study could have been too
short. Moreover, GM patterns of recovery found in our study but also
reported by Parvaz et al. (2017) stand against a predominantly neu-
rotoxic eﬀect. Thus, the changes might rather be a combination of
toxicity and maladaptation through neuroplasticity.
Therefore, the GM changes reported in the literature and found in
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this study could be linked to several underlying mechanisms. One
possible explanation for GM reduction is the notion of cocaine-induced
oxidative stress due to excessive dopamine (DA) accumulation (Pereira
et al., 2015). The involvement of the DA system in alterations seen in
the frontal cortex is likely, as this region is the major cortical target area
of DA aﬀerents (Tritsch and Sabatini, 2012). It has been shown that
cocaine acutely increases extracellular dopamine in the prefrontal
cortex (Pum et al., 2007; Saunders et al., 1994). The subsequent in-
creased metabolism due to DA accumulation leads to a buildup of re-
active oxygen species within the synaptic cleft, leading to oxidative
stress and posterior to axon terminal degeneration and possible cell
death (Jang et al., 2015; Pereira et al., 2015). The idea of a DA in-
volvement in the alterations seen is further supported by the positive
link between the prefrontal cortex's basic metabolic activity and DA
receptor depletion within subcortical regions (Volkow et al., 1993).
Further, imbalance of DA within the frontal cortex is also associated
with cognitive performance deﬁcits in working memory and attention
(Clark and Noudoost, 2014; Tritsch and Sabatini, 2012). With a positive
relationship found between CT and cognitive performance in our data,
DA-related maladjustments, leading to abnormalities in GM, might be
the neuroanatomical underpinning of cognitive deﬁcits. Alternative
explanations for GM change could also involve other neurotransmitter
systems such as GABA, as proposed by Parvaz et al. (2017). But also
neuroplastic eﬀects of the noradrenaline system might be linked to the
changes seen in GM (Havranek et al., 2017; Preller et al., 2013; Ramos
and Arnsten, 2007).
Moreover, cortical thinning, especially in frontal regions, is not
unique to addiction. The pronounced reduction of GM volume of the
frontal lobe is a common ﬁnding in aging literature (e.g., Lemaitre
et al., 2012; Raz et al., 1997). Thus, the notion arose that the reported
alterations found in GM could be indicative of an early aging brain
status in CU (Ersche et al., 2013a). The life-style of addicted individuals
is often linked to chronic stress, risky health-related behavior but also
disturbed sleep patterns, all factors which might lead to an accelerated
aging process (Bachi et al., 2017). In our study, we found changes
especially in CT, which were additionally associated with attention
performance changes. Similarly, recovery in the IFG was previously
linked to improvement in cognitive ﬂexibility (Parvaz et al., 2017).
Interestingly, a recent study showed that the mean annual percentage
change of GM in elderly subjects was higher in CT than compared to
CSA (Storsve et al., 2014). Importantly, those frontal lobe deﬁcits in
aging are also linked to cognitive performance (Zimmerman et al.,
2006).
4.2.3. Possible reasons for the lack of cortical surface area and subcortical
volume changes
The lack of change for CSA is interesting as we found that CSA for
the ACC to be smaller in CU at baseline compared to controls. Reasons
for the absence of change could again be manifold: First, the GM ab-
normalities in CSA seen at baseline could depict non-reversible neuro-
toxic eﬀects. However, we did not ﬁnd a linear relationship with drug
use parameters. Thus, if there was a neurotoxic eﬀect, this eﬀect might
at least not be dose-dependent. Second, changes in CSA may follow a
diﬀerent time trajectory for recovery than CT. Third, CSA diﬀerences
seen at baseline could represent a pre-existing state, i.e., participants
with lower CSA in ACC might be more prone to start using cocaine but
without a dose-dependent relation.
Regarding subcortical volumes we found neither a diﬀerence at
baseline between CU and controls nor a change in subcortical volumes
over the study interval. This could indicate that cocaine has either no
chronic eﬀect on the volume of subcortical structures or that the eﬀects
of cocaine on these structures are so weak that they could not be de-
tected with our medium-powered study sample. In general, more and
larger longitudinal studies investigating subcortical volumes as well as
CSA are needed to answer these open questions. Nevertheless, in regard
to CSA our results again highlight the importance of not only analyzing
GM volume, but also CT and CSA separately.
4.3. Limitations
To the best of our knowledge, this is the ﬁrst study that long-
itudinally investigated subjects with decreased but also individuals with
sustained cocaine use including MRI data and objective measurements
of cocaine use by hair testing. Nonetheless, the present results should be
interpreted with the following limitations in mind. First, our study
sample consisted of subjects using cocaine as primary drug (conﬁrmed
by quantitative hair analyses). Moreover, participants were already
using cocaine at the ﬁrst measurement time point, which might limit
the interpretability regarding preexisting vulnerability markers.
Furthermore, the time interval between the two measurement points
ranged from 6 to 53months. Although the groups were matched for
follow-up interval and we added the interval duration as a covariate in
our longitudinal analyses, we cannot completely rule out that high in-
terval variability might have inﬂuenced our results. However, as we
only have two time points available and no other study has ever re-
ported data from more than two time points, we can only speculate
about the impact the variability of the interval has. This is accentuated
by the fact that at the moment we do not know the time window of GM
recovery or the trajectory of GM change (e.g., is the change linear or
non-linear). Maybe, participants with a longer period of abstinence (or
reduction), recovered more as they had more time to do so. As stated
above, Parvaz et al., (2017) showed signiﬁcant recovery after six
months, suggesting that the ﬁrst months might be more crucial than the
following months. The notion of a nonlinear GM recovery is supported
by ﬁndings in alcohol research. Longitudinal data of GM volume
changes of the frontal cortex in alcohol dependent subjects over three
time points showed that the monthly rates of GM volume increases were
larger between one week and one month compared to the longer in-
terval between one and seven months (Durazzo et al., 2015; Zou et al.,
2018). However, generalizations over diﬀerent substances are ques-
tionable. Thus, further longitudinal studies (with> 2 time points) are
crucially needed to give some insight into this question. Lastly, al-
though we tried to include only subjects with little co-use of other
substances, exposure to other substances is nearly inevitable in most
CU. Thus, we cannot completely dismiss eﬀects of other substances.
However, additional correlations at baseline and follow-up between
other illicit drugs/alcohol consumption and GM alterations were not
signiﬁcant (Suppl. Table 6 and 7). Finally, we did not control for the
potential impact of adulterants such as levamisole. A recent study from
our laboratory showed that levamisole-exposure was associated with
alterations in fronto-cortical structures of CU (Vonmoos et al., 2018).
Unfortunately, in the present study levamisole was not determined in
hair at baseline, thus, we were not able to analyze a possible relation-
ship between changes in hair levamisole concentration and GM. The
investigation of the inﬂuence of levamisole on brain structure in future
longitudinal imaging studies with CU should be considered.
4.4. Conclusions
In summary, we found–beyond well-described frontal GM diﬀer-
ences between CU and controls at baseline–neuroanatomical changes in
frontal CT of CU depending on variations of their cocaine intake during
the study interval. Our results showed that decreased or ceased cocaine
intake lead to a signiﬁcant thickening of the lateral frontal cortex,
whereas sustained use was associated–albeit not signiﬁcantly–with
further thinning within the same region. Moreover, CT changes were
additionally related to the amount of cocaine consumed during the
follow-up interval, strengthening the suggestion that these changes are
at least partially caused by cocaine intake. Further, CT changes were
additionally associated with cognitive performance, leading to the no-
tion that GM changes might be the neuroanatomical underpinnings of
the cognitive deﬁcits commonly found in CU. Thus, our results support
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the notion that especially frontal regions are potential target regions for
psychotherapeutic and pharmacological interventions.
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